ExodusPoint Capital Management’s Organogenesis Holdings ORGO Stock Holding History

ExodusPoint Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$656K	Buy	+276,914	New	+$959K	0.01%	1119
2023 Q4	–	Sell	-123,737	Closed	-$393K	–	1901
2023 Q3	$393K	Sell	123,737 -870,887	-88%	-$2.77M	﹤0.01%	1321
2023 Q2	$3.3M	Sell	994,624 -25,777	-3%	-$76.2K	0.03%	598
2023 Q1	$2.17M	Buy	1,020,401 +845,648	+484%	+$2.09M	0.02%	841
2022 Q4	$470K	Sell	174,753 -5,702	-3%	-$16.6K	0.01%	1197
2022 Q3	$585K	Buy	180,455 +165,360	+1,095%	+$747K	0.01%	1311
2022 Q2	$74K	Sell	15,095 -89,721	-86%	-$552K	﹤0.01%	1768
2022 Q1	$799K	Buy	104,816 +90,412	+628%	+$700K	0.01%	1284
2021 Q4	$133K	Buy	+14,404	New	+$153K	﹤0.01%	1908
2021 Q3	–	Sell	-29,862	Closed	-$496K	–	2494
2021 Q2	$496K	Buy	+29,862	New	+$557K	0.01%	1441

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ExodusPoint Capital Management's ORGO Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in Organogenesis Holdings (ORGO) in Q1 2026: 276,914 shares worth $656K. The stake represents 0.01% of the portfolio and ranks #1119 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in ORGO as recently as Q3 2023.

ExodusPoint Capital Management first reported a position in ORGO in Q2 2021 and has held it in 10 quarters since. The position peaked at $3.3M in Q2 2023. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

ExodusPoint Capital Management held 276,914 shares of Organogenesis Holdings worth $656K as of Q1 2026.
Organogenesis Holdings was a new ExodusPoint Capital Management position in Q1 2026.
Organogenesis Holdings made up 0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1119 holding.
ExodusPoint Capital Management first reported a position in Organogenesis Holdings in Q2 2021 and has held it in 10 quarters since.
ExodusPoint Capital Management's Organogenesis Holdings position peaked at $3.3M in Q2 2023.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.